More than three decades ago, scientists pursued the then-radical idea of implanting tiny electronic hearing devices in the inner ear to help profoundly deaf people. An even bolder alternative that promised superior results ? implanting a device directly in the auditory nerve ? was set aside as too difficult, given the technology of the day.
At the end of what University of Michigan Health System staff members have said is among the most tragic weeks in UMHS history, there was a glimmer of hope for the future. This morning, the patient who was unable to receive a double-lung transplant when the plane carrying his organs crashed into Lake Michigan is recovering in University Hospital after being transplanted with a second set of lungs. He could be back home in several weeks.
CIGNA HealthCare announced that it has signed contracts with three major Washington providers, Swedish Medical Center, MultiCare Health System and Providence Health System.
Professor Brown and Ms Jacquie Taylor in the Illumina Genotyping Facility Scientists have isolated at least 25 genes that cause seven of the most common hereditary diseases including diabetes and arthritis in the world’s largest genetic study.
The US California Assembly approved a bill that would bring health insurers in line with other kinds of insurance in California, requiring companies to defend and get permission for increases in their premiums.
More than a third of women who suffer from diabetes during pregnancy develop type 2 diabetes within five years and those most at risk can be predicted from their blood glucose levels at diagnosis, according to a study published in the June issue of the Postgraduate Medical Journal.
Primary care practice-based research networks (PBRNs) are known as a resource for accelerating the translation of research into practice and performing research relevant to everyday primary care.
Some patients with advanced non?small-cell lung cancer (NSCLC) have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute.
Researchers at the University of Pennsylvania School of Medicine have discovered a potential new target for treating type 2 diabetes, according to a new study that appeared online this week in Nature. The target is a protein, along with its molecular partner, that regulates fat metabolism.
Taking folic acid supplements does not reduce the risk of developing precancerous tumors in the colon and may even increase the risk, a new study has found.